← Leaderboards
Robert Yarchoan
Clinical Sciences
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Clinical Sciences
Same institution · by research overlap
Others in their field
Top investigators on “Pathogenesis”
- Jeffrey P Krischer · University Of South Florida$473,867,135
- Constance Ann Benson · University Of California, San Diego$309,631,408
- Daniel R Kuritzkes · Brigham And Women'S Hospital$212,627,101
- Richard K. Wilson · Washington University$203,917,615
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$198,007,440
- Carol Nesel · Westat$147,274,423
Research focus
PathogenesisVirusBaseAids Related CancerClinical TrialsCollaborationsPharmaceutical PreparationsMalignant NeoplasmsViralHuman Herpesvirus 8Acquired Immunodeficiency SyndromeTumorHiv InfectionsCytokineDiagnosisCellsMulticentric Angiofollicular Lymphoid HyperplasiaSyndromeInflammatoryNovel TherapeuticsHerpesviridae InfectionsGanciclovirImmune ResponseZidovudine
Grant awards (76)
Clinical Trials of Patients with AIDS-Related Malignancies$1,398,422
ZIA · FY2025 · CA · contact PI
Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies$1,314,516
ZIA · FY2025 · CA · contact PI
Development of Preventive Strategies and Therapy for HIV Infection$83,905
ZIA · FY2025 · CA · contact PI
Clinical Trials of Patients with AIDS-Related Malignancies$1,675,326
ZIA · FY2024 · CA · contact PI
Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies$1,373,768
ZIA · FY2024 · CA · contact PI
Study of and development of antiviral drugs against SARS-CoV2 protease$201,039
ZIA · FY2024 · CA · contact PI
Development of Preventive Strategies and Therapy for HIV Infection$100,520
ZIA · FY2024 · CA · contact PI
Clinical Trials of Patients with AIDS-Related Malignancies$1,431,643
ZIA · FY2023 · CA · contact PI
Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies$1,173,948
ZIA · FY2023 · CA · contact PI
Study of and development of antiviral drugs against SARS-CoV2 protease$171,797
ZIA · FY2023 · CA · contact PI
Development of Preventive Strategies and Therapy for HIV Infection$85,899
ZIA · FY2023 · CA · contact PI
Clinical Trials of Patients with AIDS-Related Malignancies$1,650,515
ZIA · FY2022 · CA · contact PI
Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies$895,195
ZIA · FY2022 · CA · contact PI
Study of and development of antiviral drugs against SARS-CoV2 protease$167,849
ZIA · FY2022 · CA · contact PI
Development of Preventive Strategies and Therapy for HIV Infection$83,925
ZIA · FY2022 · CA · contact PI
Clinical Trials of Patients with AIDS-Related Malignancies$1,176,741
ZIA · FY2021 · CA · contact PI
Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies$638,233
ZIA · FY2021 · CA · contact PI
Study of and development of antiviral drugs against SARS-CoV2 protease$119,668
ZIA · FY2021 · CA · contact PI
Development of Preventive Strategies and Therapy for HIV Infection$59,835
ZIA · FY2021 · CA · contact PI
Clinical Trials of Patients with AIDS-Related Malignancies$1,018,235
ZIA · FY2020 · CA · contact PI
Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies$773,859
ZIA · FY2020 · CA · contact PI
Study of and development of antiviral drugs against SARS-CoV2 protease$203,647
ZIA · FY2020 · CA · contact PI
Development of Novel Therapies for HIV Infection$40,729
ZIA · FY2020 · CA · contact PI
Clinical Trials of Patients with AIDS-Related Malignancies$1,214,327
ZIA · FY2019 · CA · contact PI
Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies$852,159
ZIA · FY2019 · CA · contact PI
Development of Novel Therapies for HIV Infection$63,913
ZIA · FY2019 · CA · contact PI
Clinical Trials of Patients with AIDS-Related Malignancies$1,325,644
ZIA · FY2018 · CA · contact PI
Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies$930,277
ZIA · FY2018 · CA · contact PI
Development of Novel Therapies for HIV Infection$69,771
ZIA · FY2018 · CA · contact PI
Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies$1,287,015
ZIA · FY2017 · CA · contact PI
Clinical Trials of Patients with AIDS-Related Malignancies$865,406
ZIA · FY2017 · CA · contact PI
Patient Oriented Research in Viral Malignancies and HIV-associated Cancers$77,563
ZIA · FY2017 · CA · contact PI
Development of Novel Therapies for HIV Infection$66,570
ZIA · FY2017 · CA · contact PI
Clinical Trials of Patients with AIDS-Related Malignancies$667,108
ZIA · FY2016 · CA · contact PI
Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies$640,424
ZIA · FY2016 · CA · contact PI
Development of Novel Therapies for HIV Infection$26,684
ZIA · FY2016 · CA · contact PI
Clinical Trials of Patients with AIDS-Related Malignancies$1,365,193
ZIA · FY2015 · CA · contact PI
Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies$941,513
ZIA · FY2015 · CA · contact PI
Development of Novel Therapies for HIV Infection$47,076
ZIA · FY2015 · CA · contact PI
Clinical Trials of Patients with AIDS-Related Malignancies$1,118,728
ZIA · FY2014 · CA · contact PI
Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies$813,621
ZIA · FY2014 · CA · contact PI
Development of Novel Therapies for HIV Infection$101,702
ZIA · FY2014 · CA · contact PI
Clinical Trials of Patients with AIDS-Related Malignancies$1,033,298
ZIA · FY2013 · CA · contact PI
Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies$826,639
ZIA · FY2013 · CA · contact PI
Development of Novel Therapies for HIV Infection$206,660
ZIA · FY2013 · CA · contact PI
Clinical Trials of Patients with AIDS-Related Malignancies$1,313,488
ZIA · FY2012 · CA · contact PI
Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies$919,441
ZIA · FY2012 · CA · contact PI
Development of Novel Therapies for HIV Infection$394,046
ZIA · FY2012 · CA · contact PI
Clinical Trials of Patients with AIDS-Related Malignancies$1,313,319
ZIA · FY2011 · CA · contact PI
Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies$919,323
ZIA · FY2011 · CA · contact PI
Development of Novel Therapies for HIV Infection$393,996
ZIA · FY2011 · CA · contact PI
Clinical Trials of Patients with AIDS-Related Malignancies$1,007,955
ZIA · FY2010 · CA · contact PI
Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies$671,971
ZIA · FY2010 · CA · contact PI
Development of Novel Therapies for HIV Infection$559,976
ZIA · FY2010 · CA · contact PI
Clinical trials of patients with AIDS-related malignancies$1,032,501
ZIA · FY2009 · CA · contact PI
Study of tumor pathogenesis and development of therapies for AIDS-malignancies$688,334
ZIA · FY2009 · CA · contact PI
Development of Novel Therapies for HIV Infection$573,612
ZIA · FY2009 · CA · contact PI
Clinical trials of patients with AIDS-related malignancies$905,688
Z01 · FY2008 · CA · contact PI
Study of tumor pathogenesis and development of therapies for AIDS-malignancies$662,698
Z01 · FY2008 · CA · contact PI
Development of Novel Therapies for HIV Infection$618,518
Z01 · FY2008 · CA · contact PI
Pediatric HIVAIDS Clinical Research$22,090
Z01 · FY2008 · CA · contact PI
Development of Novel Therapies for HIV Infection and AIDS-Related Malignancies$2,463,925
Z01 · FY2007 · CA · contact PI
Pediatric HIVAIDS Clinical Research$182,878
Z01 · FY2007 · CA · contact PI
Pediatric HIVAIDS Clinical Research$0
Z01 · FY2006 · SC · contact PI
Development of Novel Therapies for HIV Infection and AID$0
Z01 · FY2006 · SC · contact PI
Pediatric HIVAIDS Clinical Research$0
Z01 · FY2005 · SC
Development of Novel Therapies for HIV Infection and AID$0
Z01 · FY2005 · SC
Pediatric HIV/AIDS Clinical Research$0
Z01 · FY2004 · SC
Novel Therapies for HIV Inf. &AIDS-Related Malignancies$0
Z01 · FY2004 · SC
Pediatric HIV/AIDS Clinical Research$0
Z01 · FY2003 · SC
Pediatric HIV/AIDS Clinical Research$0
Z01 · FY2002 · SC
Development of Novel Therapies for HIV Infection and AID$0
Z01 · FY2002 · SC
Pediatric HIV/AIDS Clinical Research$0
Z01 · FY2001 · SC
Development of Novel Therapies for HIV Infection and Rel$0
Z01 · FY2001 · SC
Pediatric HIV/AIDS Clinical Research$0
Z01 · FY2000 · SC
Development of Novel Therapies for HIV Infection and Related Malignancies$0
Z01 · FY2000 · SC